Lataa...

The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies

BACKGROUND: A previous six-week (wk) study demonstrated the potential of the sodium-glucose linked transport inhibitor velagliflozin as a novel treatment for equine insulin dysregulation. The present study examined the safety and efficacy of velagliflozin over 16 wk. of treatment, and over 4 wk. of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Vet Res
Päätekijät: Meier, A., de Laat, M., Reiche, D., Fitzgerald, D., Sillence, M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6390376/
https://ncbi.nlm.nih.gov/pubmed/30808423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-019-1811-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!